Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Post

Showing results (291-300 of 773) with videos related to

Pageof 78
Sort By:
European Heart Journal|September 11, 2021
Atherothrombotic factors and atherosclerotic cardiovascular events: the multi-ethnic study of atherosclerosisAndrew P DeFilippis, Patrick J Trainor, George Thanassoulis, et al.
Der Anaesthesist|September 21, 2007
[Elective colon resection in Germany. A survey of the perioperative anesthesiological management]T Hasenberg, M Niedergethmann, P Rittler, et al.
Gastroenterology Research and Practice|April 11, 2015
Does the Addition of Cetuximab to Radiochemotherapy Improve Outcome of Patients with Locally Advanced Rectal Cancer? Long-Term Results from Phase II TrialsM Kripp, K Horisberger, S Mai, et al.
Chest|March 13, 2002
Interaction of hemostatic genetics with hormone therapy: new insights to explain arterial thrombosis in postmenopausal womenJoel B Braunstein, Dawn Warner Kershner, Paul Bray, et al.
Journal of Feline Medicine and Surgery|November 28, 2017
Retrospective evaluation of toceranib phosphate (Palladia) use in cats with mast cell neoplasiaErika P Berger, Chad M Johannes, Gerald S Post, et al.
The Journal of Clinical Endocrinology and Metabolism|September 13, 2003
Effect of hormone replacement therapy on plasma levels of the cardiovascular risk factor asymmetric dimethylarginine: a randomized, placebo-controlled 12-week study in healthy early postmenopausal womenMarinka S Post, Marieke O Verhoeven, Marius J van der Mooren, et al.
Open Heart|January 22, 2022
Diastolic dysfunction in people with HIV without known cardiovascular risk factors in Western KenyaBethel Woldu, Tecla M Temu, Nicholas Kirui, et al.
American Journal of Obstetrics and Gynecology|September 25, 2001
Raloxifene reduces impedance to flow within the uterine artery in early postmenopausal women: a 2-year randomized, placebo-controlled, comparative studyM S Post, M J van der Mooren, W M van Baal, et al.
American Heart Journal|November 4, 2004
Underlying risk factors incrementally add to the standard risk estimate in detecting subclinical atherosclerosis in low- and intermediate-risk middle-aged asymptomatic individualsMilind Y Desai, Khurram Nasir, Joel B Braunstein, et al.
Journal of Physiology and Pharmacology : an Official Journal of the Polish Physiological Society|March 28, 2008
Alterations of tumor and normal tissue of human lung cancer resection specimens after isolation perfusionK Nowak, C Hanusch, H C Kölbel, et al.
Pageof 78

Showing results (291-300 of 773) with videos related to

Sort By:
Pageof 78
European Heart Journal|September 11, 2021
Atherothrombotic factors and atherosclerotic cardiovascular events: the multi-ethnic study of atherosclerosisAndrew P DeFilippis, Patrick J Trainor, George Thanassoulis, et al.
Der Anaesthesist|September 21, 2007
[Elective colon resection in Germany. A survey of the perioperative anesthesiological management]T Hasenberg, M Niedergethmann, P Rittler, et al.
Gastroenterology Research and Practice|April 11, 2015
Does the Addition of Cetuximab to Radiochemotherapy Improve Outcome of Patients with Locally Advanced Rectal Cancer? Long-Term Results from Phase II TrialsM Kripp, K Horisberger, S Mai, et al.
Chest|March 13, 2002
Interaction of hemostatic genetics with hormone therapy: new insights to explain arterial thrombosis in postmenopausal womenJoel B Braunstein, Dawn Warner Kershner, Paul Bray, et al.
Journal of Feline Medicine and Surgery|November 28, 2017
Retrospective evaluation of toceranib phosphate (Palladia) use in cats with mast cell neoplasiaErika P Berger, Chad M Johannes, Gerald S Post, et al.
The Journal of Clinical Endocrinology and Metabolism|September 13, 2003
Effect of hormone replacement therapy on plasma levels of the cardiovascular risk factor asymmetric dimethylarginine: a randomized, placebo-controlled 12-week study in healthy early postmenopausal womenMarinka S Post, Marieke O Verhoeven, Marius J van der Mooren, et al.
Open Heart|January 22, 2022
Diastolic dysfunction in people with HIV without known cardiovascular risk factors in Western KenyaBethel Woldu, Tecla M Temu, Nicholas Kirui, et al.
American Journal of Obstetrics and Gynecology|September 25, 2001
Raloxifene reduces impedance to flow within the uterine artery in early postmenopausal women: a 2-year randomized, placebo-controlled, comparative studyM S Post, M J van der Mooren, W M van Baal, et al.
American Heart Journal|November 4, 2004
Underlying risk factors incrementally add to the standard risk estimate in detecting subclinical atherosclerosis in low- and intermediate-risk middle-aged asymptomatic individualsMilind Y Desai, Khurram Nasir, Joel B Braunstein, et al.
Journal of Physiology and Pharmacology : an Official Journal of the Polish Physiological Society|March 28, 2008
Alterations of tumor and normal tissue of human lung cancer resection specimens after isolation perfusionK Nowak, C Hanusch, H C Kölbel, et al.
Pageof 78